Craving Clinical Trial
— ProcravOfficial title:
Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving
The aim of this study is to have a better understanding of the relationship between self-controle difficulties (and more specifically the inhibition deficit in impulsivity), emotional regulation disorders such as alexithymia and craving.This study will be the first in France to specify the interactions between self-regulkation processes dysfunctions and emotional dysfunctions in craving.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | November 20, 2021 |
Est. primary completion date | November 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patient, men or women between 18 and 60 years-old - Patient with a diagnosis of moderate to severe dependence (DSM 5) to cocaine with or without co-addictions to alcohol or psychostimulant. - Patient on day-hospitalisation or full hospitalisation - Patient affiliated or beneficiary to a social security scheme. - Patient having signed the free and informed consent. Exclusion Criteria: - Patient with psychiatric disorders psychosis type - Patient with severe chronic somatic disease. - Patient participating in another clinical study - Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision. - Pregnant, breastfeeding or parturient woman. - Patient hospitalized without consent. |
Country | Name | City | State |
---|---|---|---|
France | Clinique privée | Marseille |
Lead Sponsor | Collaborator |
---|---|
Ramsay Générale de Santé | Ramsay santé |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cocaïne craving evaluation | Using the French version of the questionnaire CCQ-Brief "Cocaïne Craving Questionnaire". | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Not yet recruiting |
NCT06026982 -
Gut Health and the Effect on Substance and Alcohol Cravings
|
Early Phase 1 | |
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Completed |
NCT05074524 -
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
|
N/A | |
Completed |
NCT03112824 -
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
|
N/A | |
Completed |
NCT03758027 -
CARESS: An Investigation of Effects of CARESS
|
N/A | |
Not yet recruiting |
NCT03217929 -
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.
|
N/A | |
Completed |
NCT01030289 -
The Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Decreasing Food Cravings
|
N/A | |
Withdrawn |
NCT04077385 -
Memory-Updating Technique to Reduce Food Craving and High Calorie Food Intake Among Individuals With Overweight/Obesity
|
N/A | |
Completed |
NCT04310423 -
An Inflammatory Challenge Using Endotoxin
|
Phase 2 | |
Not yet recruiting |
NCT06129461 -
A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy
|
N/A | |
Recruiting |
NCT04338178 -
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.
|
N/A | |
Terminated |
NCT04162145 -
BRIDGE Device for Treatment of Opioid Withdrawal
|
N/A | |
Completed |
NCT05430685 -
The Impact of Ashwagandha on Perceived Stress, Sleep and Food Cravings in College Students
|
Phase 2 | |
Recruiting |
NCT04154111 -
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
|
N/A | |
Recruiting |
NCT05277714 -
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
|
N/A | |
Completed |
NCT04936594 -
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
|
N/A | |
Enrolling by invitation |
NCT05336188 -
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
|
Phase 2 | |
Recruiting |
NCT04850664 -
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
|
Phase 2 | |
Not yet recruiting |
NCT06247306 -
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
|
N/A |